ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
Targeting mitochondrial oncoproteins presents a new concept in the development of effective cancer therapeutics. ATAD3A is a nuclear-encoded mitochondrial enzyme contributing to mitochondrial dynamics, cholesterol metabolism, and signal transduction. However, its impact and underlying regulatory mec...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | inglés |
Publicado: |
2022
|
Acceso en línea: | https://doi.org/10.1186/s13046-022-02274-9 https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-022-02274-9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|